Inflammatory Diseases Biologics Market Size 2025: Key Developments, Future Growth, Industry Insights, Detailed Report | Top Companies - Pfizer Inc., F. Hoffmann-La Roche Ltd, GSK, AbbVie, Sanofi

global inflammatory diseases biologics market size was US$ 99.06 Billion in 2024 and is expected to reach US$ 157.31 Billion by 2033, growing at a CAGR of 5.3% during the forecast period 2025-2033.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/inflammatory-diseases-biologics-market?kb

Key Highlights From This Report

✅ North America leads the global inflammatory diseases biologics market, accounting for 48.5% of revenue in 2024.

✅ Asia Pacific is the fastest-growing region, recording a CAGR of 7.7% in 2024.

✅ Anti-TNF inhibitors hold the largest drug class share, representing 44.3% of the market in 2024.

✅ Rheumatoid arthritis remains the leading indication, capturing 40.3% of the market in 2024.

Key Players:

Amgen Inc., Novartis Pharmaceuticals Corporation, Johnson & Johnson, Pfizer Inc., F. Hoffmann-La Roche Ltd, GSK, AbbVie, Sanofi, Eli Lilly and Company, and Takeda Pharmaceuticals U.S.A., Inc

Key industry Development:

✅ August: Accord BioPharma launched IMULDOSA (ustekinumab-srlf), a biosimilar to STELARA, for conditions like psoriasis and Crohn's, improving affordable access.

✅ March: Celltrion's OMLYCLO (omalizumab-igec) became the first FDA-approved interchangeable biosimilar to XOLAIR, for asthma and allergic conditions.

✅ June: Sanofi's Dupixent (dupilumab) received FDA approval as the first targeted biologic for adult bullous pemphigoid patients.

✅ May: Biocon Biologics secured UK approval for YESINTEK, its ustekinumab biosimilar, for psoriasis, psoriatic arthritis, and Crohn's disease.

Growth Forecast Projection:

The Global Inflammatory Diseases Biologics Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Inflammatory Diseases Biologics Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=inflammatory-diseases-biologics-market?kb

Key Segmentation:

By Drug Class: (Anti-Tumor Necrosis Factor (TNF) inhibitors, Interleukin antagonists, Janus Kinase (JAK) inhibitors, Others)

By Disease Indication: (Rheumatoid Arthritis, Psoriasis, Inflammatory Bowel Disease, Ankylosing Spondylitis, Others)

By Distribution Channel: (Hospital Pharmacies, Retail Pharmacies)

Regional Analysis for Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among Inflammatory Diseases Biologics producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze Inflammatory Diseases Biologics revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/inflammatory-diseases-biologics-market?kb

FAQ's

Q1: What is the current size of the Inflammatory Diseases Biologics Market?

A: The Inflammatory Diseases Biologics Market stood at US$ 99.06 Billion in 2024 and is set to experience remarkable growth, reaching US$ 157.31 Billion by 2033

Q2: How fast is the Inflammatory Diseases Biologics Market growing?

A: The Market is on an impressive growth trajectory, expected to expand at a CAGR of 5.3% from 2025 to 2032

Have any Enquiry of This Report @ https://www.datamintelligence.com/enquiry/inflammatory-diseases-biologics-market?kb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.